Radio and PodcastRadio and PodcastLive Radio & Podcasts
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab artwork
Health

Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck by American Medical Association

Jul 31, 202517:45Health

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related...